July 2019 to June 2023 Saw Increase in OD Deaths With Ketamine Detected

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, Nov. 8, 2024 -- During July 2019 to June 2023, there was an increase in overdose deaths with ketamine detected, according to research published in the Nov. 7 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Alana M. Vivolo-Kantor, Ph.D., from the CDC in Atlanta, and colleagues analyzed data from the CDC State Unintentional Drug Overdose Reporting System to describe the characteristics of and trends in overdose deaths with ketamine detected or involved from July 2019 to June 2023.

The researchers identified 228,668 drug overdose deaths in 45 jurisdictions during July 2019 to June 2023. Ketamine was detected and was listed as involved in 0.4 and 0.2 percent of overdose deaths, respectively, and was the only substance involved in 0.01 percent of deaths. Most deaths with ketamine detected involved illegally manufactured fentanyls (IMFs), methamphetamine, and cocaine (58.7, 28.8, and 27.2 percent, respectively); 82.4 percent of deaths involved IMFs, methamphetamine, or cocaine. Among the decedents in whom ketamine was detected, 34.8, 71.3, and 73.7 percent were aged 25 to 34 years, were male, and were non-Hispanic Whites, respectively. There was an increase in the number and percentage of deaths with ketamine detected from July 2019 to June 2023, from 0.3 to 0.5 percent; notable increases were seen as early as July to December 2020.

"As polysubstance use and use of ketamine for treatment-resistant depression and in compounded formulations increase, continued monitoring is needed to identify potential changes in the detection and involvement of ketamine in overdose deaths," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-11-10 00:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords